Event-Related Potentials in Alcoholic Men: P3 Amplitude Reflects Family History But Not Alcohol Consumption

1991 ◽  
Vol 15 (5) ◽  
pp. 839-850 ◽  
Author(s):  
Adolf Pfefferbaum ◽  
Judith M. Ford ◽  
Patricia M. White ◽  
Daniel Mathalon
2003 ◽  
Vol 15 (2) ◽  
pp. 294-313 ◽  
Author(s):  
K. R. Daffner ◽  
L. F. M. Scinto ◽  
A. M. Weitzman ◽  
R. Faust ◽  
D. M. Rentz ◽  
...  

Despite the important role that attending to novel events plays in human behavior, there is limited information about the neuroanatomical underpinnings of this vital activity. This study investigated the relative contributions of the frontal and posterior parietal lobes to the differential processing of novel and target stimuli under an experimental condition in which subjects actively directed attention to novel events. Event-related potentials were recorded from well-matched frontal patients, parietal patients, and non-brain-injured subjects who controlled their viewing duration (by button press) of line drawings that included a frequent, repetitive background stimulus, an infrequent target stimulus, and infrequent, novel visual stimuli. Subjects also responded to target stimuli by pressing a foot pedal. Damage to the frontal cortex resulted in a much greater disruption of response to novel stimuli than to designated targets. Frontal patients exhibited a widely distributed, profound reduction of the novelty P3 response and a marked diminution of the viewing duration of novel events. In contrast, damage to posterior parietal lobes was associated with a substantial reduction of both target P3 and novelty P3 amplitude; however, there was less disruption of the processing of novel than of target stimuli. We conclude that two nodes of the neuroanatomical network for responding to and processing novelty are the prefrontal and posterior parietal regions, which participate in the voluntary allocation of attention to novel events. Injury to this network is indexed by reduced novelty P3 amplitude, which is tightly associated with diminished attention to novel stimuli. The prefrontal cortex may serve as the central node in determining the allocation of attentional resources to novel events, whereas the posterior parietal lobe may provide the neural substrate for the dynamic process of updating one's internal model of the environment to take into account a novel event.


1987 ◽  
Vol 150 (2) ◽  
pp. 154-160 ◽  
Author(s):  
D. H. R. Blackwood ◽  
L. J. Whalley ◽  
J. E. Christie ◽  
I. M. Blackburn ◽  
D. M. St Clair ◽  
...  

Event-related potentials during a two-tone discrimination task were recorded in 24 schizophrenic patients, 16 depressed patients and 59 control subjects. Recordings were made when patients were medication-free. Fourteen schizophrenic and 13 depressed patients were retested at 1 and 4 weeks after the start of treatment, and 13 schizophrenic patients were also tested between 6 and 24 months after the initial recordings. In the schizophrenic group, the P3 latency was significantly prolonged compared with that in the control and the depressed groups, and remained unchanged both after 4 weeks treatment with therapeutic doses of neuroleptic drugs and at long-term follow-up. In the depressed group, the P3 latency did not differ from that of controls. P3 amplitude by contrast was reduced in both the acutely depressed and schizophrenic groups and following treatment became normal in the depressed group but remained reduced in the schizophrenic group. It is suggested that a prolonged P3 latency and reduced P3 amplitude indicate an impairment of auditory information processing in some patients with schizophrenia which is independent of the presence of acute psychotic symptoms and is not influenced by neuroleptic medication.


2021 ◽  
Vol 12 ◽  
Author(s):  
Qiaoling Sun ◽  
Yehua Fang ◽  
Yongyan Shi ◽  
Lifeng Wang ◽  
Xuemei Peng ◽  
...  

Objective: Auditory verbal hallucinations (AVH), with unclear mechanisms, cause extreme distresses to schizophrenia patients. Deficits of inhibitory top-down control may be linked to AVH. Therefore, in this study, we focused on inhibitory top-down control in schizophrenia patients with AVH.Method: The present study recruited 40 schizophrenia patients, including 20 AVH patients and 20 non-AVH patients, and 23 healthy controls. We employed event-related potentials to investigate the N2 and P3 amplitude and latency differences among these participants during a Go/NoGo task.Results: Relative to healthy controls, the two patient groups observed longer reaction time (RT) and reduced accuracy. The two patient groups had smaller NoGo P3 amplitude than the healthy controls, and the AVH patients showed smaller NoGo P3 amplitude than the non-AVH patients. In all the groups, the parietal area showed smaller NoGo P3 than frontal and central areas. However, no significant difference was found in N2 and Go P3 amplitude between the three groups.Conclusions: AVH patients might have worse inhibitory top-down control, which might be involved in the occurrence of AVH. Hopefully, our results could enhance understanding of the pathology of AVH.


Cephalalgia ◽  
2003 ◽  
Vol 23 (7) ◽  
pp. 545-551 ◽  
Author(s):  
A Frese ◽  
K Frese ◽  
EB Ringelstein ◽  
I-W Husstedt ◽  
S Evers

Cognitive processing as measured by event-related potentials (ERP) in patients suffering from the explosive subtype of headache associated with sexual activity (HSA type 2) was investigated. Visual ERP were measured in 24 patients with HSA type 2 outside the headache period. The differences of the first and the second part of measurement were evaluated separately to determine the amount of cognitive habituation. Twenty-four sex- and age-matched healthy subjects and 24 patients with migraine without aura served as controls. A missing increase of P3 latency during the second part of the measurement was found in 79% of patients with HSA type 2 and in 75% with migraine, but only in 17% of the healthy controls ( P < 0.001). The P3 amplitude was increased during the second part in 71% of patients with HSA type 2 and in 79% with migraine, but only in 33% of the healthy controls ( P = 0.02). Mean P3 latency was decreased and mean P3 amplitude was increased during the second part of the measurement in HSA type 2 and in migraine but not in the healthy control group. Patients with HSA type 2 have a loss of cognitive habituation as measured by ERP. This specific information processing is very similar to that in migraine observed in previous studies.


2016 ◽  
Vol 23 (4) ◽  
pp. 618-624 ◽  
Author(s):  
Roman Chwedorowicz ◽  
Grzegorz Raszewski ◽  
Lucyna Kapka-Skrzypczak ◽  
Krzysztof Sawicki ◽  
Tadeusz Studziński

Alcohol ◽  
1987 ◽  
Vol 4 (4) ◽  
pp. 265-274 ◽  
Author(s):  
Bradley W. Patterson ◽  
Harold L. Williams ◽  
Garnet A. McLean ◽  
Landgrave T. Smith ◽  
Kim Walter Schaeffer

2013 ◽  
Vol 48 (4) ◽  
pp. 464-471 ◽  
Author(s):  
Eduardo López-Caneda ◽  
Fernando Cadaveira ◽  
Alberto Crego ◽  
Sonia Doallo ◽  
Montserrat Corral ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Carl Delfin ◽  
Emily Ruzich ◽  
Märta Wallinius ◽  
Malin Björnsdotter ◽  
Peter Andiné

Trait disinhibition may function as a dispositional liability toward maladaptive behaviors relevant in the treatment of mentally disordered offenders (MDOs). Reduced amplitude and prolonged latency of the NoGo N2 and P3 event-related potentials have emerged as promising candidates for transdiagnostic, biobehavioral markers of trait disinhibition, yet no study has specifically investigated these two components in violent, inpatient MDOs. Here, we examined self-reported trait disinhibition, experimentally assessed response inhibition, and NoGo N2 and P3 amplitude and latency in male, violent MDOs (N = 27) and healthy controls (N = 20). MDOs had a higher degree of trait disinhibition, reduced NoGo P3 amplitude, and delayed NoGo P3 latency compared to controls. The reduced NoGo P3 amplitude and delayed NoGo P3 latency in MDOs may stem from deficits during monitoring or evaluation of behavior. NoGo P3 latency was associated with increased trait disinhibition in the whole sample, suggesting that trait disinhibition may be associated with reduced neural efficiency during later stages of outcome monitoring or evaluation. Findings for NoGo N2 amplitude and latency were small and non-robust. With several limitations in mind, this is the first study to demonstrate attenuated NoGo P3 amplitude and delayed NoGo P3 latency in violent, inpatient MDOs compared to healthy controls.


Sign in / Sign up

Export Citation Format

Share Document